endocrine:start
This is an old revision of the document!
Endocrine Pharmacology
Endocrine pharmacology is organized by hormonal organ systems.
Each section links to physiology, pathophysiology, drug classes, and therapeutic strategy.
Diabetes & Glucose Regulation
1. Hypoglycemics (Increase Insulin Effect)
These agents increase insulin levels and carry hypoglycemia risk. Insulin Therapy
Rapid-Acting (Prandial)
Short-Acting
- Regular Insulin (Humulin R®, Novolin R®)
Intermediate-Acting
- NPH (Humulin N®, Novolin N®)
Long-Acting (Basal)
Ultra-Long Acting
- Degludec (Tresiba®)
- Glipizide (Glucotrol®)
- Glyburide (Diabeta®, Glynase®)
- Glimepiride (Amaryl®)
- Repaglinide (Prandin®)
- Nateglinide (Starlix®)
2. Anti-Hyperglycemics (Low Hypoglycemia Risk)
These agents improve glycemia without directly increasing insulin secretion.
- Metformin (Glucophage®)
- Pioglitazone (Actos®)
- Rosiglitazone (Avandia®)
- Exenatide (Byetta®, Bydureon®)
- Liraglutide (Victoza®, Saxenda®)
- Dulaglutide (Trulicity®)
- Semaglutide (Ozempic®, Wegovy®, Rybelsus®)
Dual GLP-1/GIP Incretin Agonists
- Tirzepatide (Mounjaro®, Zepbound®)
- Retatrutide (Investigational)
- Dapagliflozin (Farxiga®)
- Empagliflozin (Jardiance®)
- Sotagliflozin (Inpefa®)
Thyroid
Thyroid Hormone Replacement
- Levothyroxine (Synthroid®, Levoxyl®)
- Liothyronine (Cytomel®)
- Liotrix (Thyrolar®)
Antithyroid Drugs
- Methimazole (Tapazole®)
Iodine Therapy
Symptom Control in Hyperthyroidism
Adrenal
- Prednisone (Deltasone®)
- Hydrocortisone (Cortef®)
- Dexamethasone (Decadron®)
- Fludrocortisone (Florinef®)
- Ketoconazole
- Metyrapone
Pituitary
- Cabergoline (Dostinex®)
- Bromocriptine (Parlodel®)
- Octreotide (Sandostatin®)
- Lanreotide (Somatuline®)
- Desmopressin (DDAVP®)
Reproductive Endocrinology
Selective Estrogen Receptor Modulators (SERMs)
- Tamoxifen (Nolvadex®)
- Raloxifene (Evista®)
- Spironolactone (Aldactone®)
- Finasteride (Proscar®, Propecia®)
Bone & Mineral Metabolism
Anti-Resorptive Agents
[[endocrine:bone:bisphosphonates|Bisphosphonates]]
Oral:
- Alendronate (Fosamax®)
- Risedronate (Actonel®)
- Ibandronate (Boniva®)
IV:
- Zoledronic Acid (Reclast®, Zometa®)
- Pamidronate (Aredia®)
Used in:
- Osteoporosis
- Paget disease
- Hypercalcemia of malignancy
- Bone metastases
[[endocrine:bone:rankl_inhibitors|RANKL Inhibitors]]
- Denosumab (Prolia®, Xgeva®)
[[endocrine:serm:start|Selective Estrogen Receptor Modulators (SERMs)]]
- Raloxifene (Evista®)
[[endocrine:calcitonin|Calcitonin]]
Anabolic / Bone-Forming Agents
[[endocrine:bone:pth_analogs|Parathyroid Hormone Analogs]]
- Teriparatide (Forteo®)
- Abaloparatide (Tymlos®)
[[endocrine:bone:sclerostin_inhibitors|Sclerostin Inhibitors]]
- Romosozumab (Evenity®)
Vitamin D & Calcium Axis
[[endocrine:bone:vitamin_d|Vitamin D & Analogs]]
Nutritional:
- Cholecalciferol (Vitamin D3)
- Ergocalciferol (Vitamin D2)
Active Forms:
- Calcitriol (Rocaltrol®)
- Paricalcitol (Zemplar®)
- Doxercalciferol (Hectorol®)
Calcium Supplements
Hyperparathyroidism / CKD-MBD
[[endocrine:bone:calcimimetics|Calcimimetics]]
- Cinacalcet (Sensipar®)
- Etelcalcetide (Parsabiv®)
Phosphate Binders
Calcium-based:
Non-calcium:
- Sevelamer (Renvela®)
- Lanthanum (Fosrenol®)
- Sucroferric Oxyhydroxide (Velphoro®)
- Ferric Citrate (Auryxia®)
FGF23 Pathway
Clinical Groupings
Osteoporosis:
- Bisphosphonates
- Denosumab
- Teriparatide / Abaloparatide
- Romosozumab
- Raloxifene
CKD–Mineral Bone Disease:
- Vitamin D analogs
- Calcimimetics
- Phosphate binders
Hypercalcemia:
- IV Bisphosphonates
- Denosumab
- Calcitonin
Paget Disease:
- Bisphosphonates
Related:
endocrine/start.1770991618.txt.gz · Last modified: by andrew2393cns
